US Pharma MarketingCreate Medicines fashions $122M fundraise for in vivo CAR-T dreams
Create Medicines fashions $122M fundraise for in vivo CAR-T dreams is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
As the wave of in vivo CAR-T hype crests, Create Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates.
Source: FierceBiotech